# Diligent Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diligent-pharma

- Industry: Software
- Headquarters: Princeton, US
- Website: www.diligentpharma.com
- Total disclosed funding: $3.5M
- Latest round: Series A (Feb 2, 2023)
- Investors on record: 3

## About

Based in New Jersey, US, and founded in 2018 by CEO Patricia Leuchten, Diligent Pharma, Inc. is a provider of quality and risk mitigation in clinical trial execution through the centralization of qualification and vendor management practices and the harnessing of data and insight. In May 2023, Diligent Pharma, Inc. raised USD 8.27 million in series A funding led by investor FCA Venture Partners, with participation from other investors PJC and GenHenn Capital.

The company offers a cloud-based diligence qualification platform that provides a comprehensive request for information (RFI) details for industry suppliers as well as vendor qualification assessments (VQAs) for multiple clients. The platform allows sponsors to identify and assess providers faster by using standardized RFIs and VQAs, which provide efficiencies and time savings for sponsors and service providers across the clinical trial ecosystem.

## Funding rounds

- Series A, Feb 2, 2023, $3.5M — PJC, FCA Venture Partners, GenHenn Capital

## Investors

- PJC (https://capitalatlas.ai/funds/pjc) — Series A
- FCA Venture Partners (https://capitalatlas.ai/funds/fca-venture-partners) — Series A
- GenHenn Capital — Series A